Anti-aging drug targets Alzheimer’s by altering metabolism in the brain
Scientists investigating Alzheimer’s treatments at the Salk Institute have uncovered some key mechanisms that enable an experimental drug to reverse memory loss in mouse models of the disease. The discovery not only bodes well for the possibility of clinical trials, but provides researchers with a new target to consider in the wider development of compounds to counter the degenerative effects of the condition.
Tags: Alzheimer’s Disease, Salk Institute, Neurological, Dementia, Brain, New Atlas Audio
Continue reading Anti-aging drug targets Alzheimer’s by altering metabolism in the brain